Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 30;56(1):2001365.
doi: 10.1183/13993003.01365-2020. Print 2020 Jul.

Pulmonary embolism in patients with COVID-19 pneumonia

Florian Bompard  1 , Hippolyte Monnier  2 , Ines Saab  1   3 , Mickael Tordjman  1 , Hendy Abdoul  4 , Laure Fournier  2   3 , Olivier Sanchez  3   5 , Christine Lorut  6 , Guillaume Chassagnon  1   3 , Marie-Pierre Revel  7   3
Affiliations

Pulmonary embolism in patients with COVID-19 pneumonia

Florian Bompard et al. Eur Respir J. .

Abstract

This study reports an overall 24% (95% CI 17–32%) cumulative incidence of pulmonary embolism in patients with COVID-19 pneumonia, 50% (30–70%) in ICU and 18% (12–27%) in other patients https://bit.ly/35s7hjm

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: F. Bompard has nothing to disclose. Conflict of interest: H. Monnier has nothing to disclose. Conflict of interest: I. Saab has nothing to disclose. Conflict of interest: M. Tordjman has nothing to disclose. Conflict of interest: H. Abdoul has nothing to disclose. Conflict of interest: L. Fournier reports personal fees for lectures from General Electric, Janssen and Novartis, non-financial support from Guerbet, outside the submitted work. Conflict of interest: O. Sanchez reports personal fees and non-financial support from BTG, grants and personal fees from Boston Scientific, grants, personal fees and non-financial support from Bayer and BMS, personal fees from Sanofi Aventis, grants from Daiichi Sankyo, during the conduct of the study; grants, personal fees and non-financial support from MSD, grants from Boehringer Ingelheim, outside the submitted work. Conflict of interest: C. Lorut reports non-financial support from Covidien AG, Novatech SA and Proxilio, outside the submitted work. Conflict of interest: G. Chassagnon has nothing to disclose. Conflict of interest: M-P. Revel reports personal fees for lectures from MSD France, travel support from Guerbet, outside the submitted work.

Comment in

References

    1. Wu C, Chen X, Cai Y, et al. . Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020; 180: 1–11. - PMC - PubMed
    1. Guo T, Fan Y, Chen M, et al. . Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; 5: 1–8. - PMC - PubMed
    1. Tang N, Li D, Wang X, et al. . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844–847. doi:10.1111/jth.14768 - DOI - PMC - PubMed
    1. Klok FA, Kruip MJHA, van der Meer NJM, et al. . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191: 145–147. - PMC - PubMed
    1. Revel M-P, Parkar AP, Prosch H, et al. . COVID-19 patients and the radiology department – advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Eur Radiol; in press [10.1007/s00330-020-06865-y]. - DOI - PMC - PubMed

MeSH terms

Substances